Project overview: A strategy to increase demand for retired Thoroughbreds in Australia
The Thoroughbred industry in Australia is the second largest in the world, both in terms of breeding and the number of races held. The industry...
THOROUGHBRED HORSES
45 pages
Published: 1 Sep 2005
Author(s): Whalley, J M
Download report PDF
DownloadPurchase a hard copy - AUD $45.00
This report describes development towards potential new vaccines for EHV-1. Firstly the immunogenicity of a formulation containing EHV-1 envelope glycoproteins was tested by measuring antibody responses of mares and young foals. Secondly, in order to provide a system whereby these and other vaccines could be assessed, an experimental EHV-1 respiratory challenge model of infection was established in mares and foals, using an Australian isolate of EHV-1. This model was then used to determine whether the immune responses to the glycoprotein formulation could provide protection against EHV-1 infection.